← Leaderboards
Lynn Kozma
Nirmidas Biotech, Inc.
$804,811
Attributed
$804,811
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$804,811 · 1
By mechanism
R44$804,811 · 1
Top collaborators
No co-investigators on record.
Most similar at Nirmidas Biotech, Inc.
Same institution · by research overlap
- Jeyarama Ananta$707,549
- Joshua Tucker Robinson$206,973
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesAntigensAssay DevelopmentAutoantibodiesBaseBiological MarkersBiotechnologyCell InjuryChildChildhoodCohortComputer SoftwareCost EffectiveData AcquisitionData SetDetectionDiabetes AutoantibodiesDiabetes ControlDiabetes MellitusDiabetes PreventionDiagnosisDiagnosticEarly Diagnosis4 Year Old